Goldman Sachs’s Pacira BioSciences PCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$31.3M Buy
1,308,901
+204,105
+18% +$4.88M ﹤0.01% 1452
2025
Q1
$27.5M Buy
1,104,796
+367,869
+50% +$9.14M ﹤0.01% 1467
2024
Q4
$13.9M Buy
736,927
+393,544
+115% +$7.41M ﹤0.01% 2075
2024
Q3
$5.17M Sell
343,383
-9,487
-3% -$143K ﹤0.01% 2734
2024
Q2
$10.1M Buy
352,870
+135,916
+63% +$3.89M ﹤0.01% 2079
2024
Q1
$6.34M Buy
216,954
+13,900
+7% +$406K ﹤0.01% 2389
2023
Q4
$6.85M Buy
203,054
+30,319
+18% +$1.02M ﹤0.01% 2364
2023
Q3
$5.3M Sell
172,735
-19,258
-10% -$591K ﹤0.01% 2431
2023
Q2
$7.69M Buy
191,993
+8,879
+5% +$356K ﹤0.01% 2246
2023
Q1
$7.47M Buy
183,114
+57,096
+45% +$2.33M ﹤0.01% 2230
2022
Q4
$4.87M Buy
126,018
+5,936
+5% +$229K ﹤0.01% 2643
2022
Q3
$6.39M Buy
120,082
+10,973
+10% +$584K ﹤0.01% 2465
2022
Q2
$6.36M Buy
109,109
+2,749
+3% +$160K ﹤0.01% 2464
2022
Q1
$8.12M Sell
106,360
-70,274
-40% -$5.36M ﹤0.01% 2418
2021
Q4
$10.6M Sell
176,634
-259,052
-59% -$15.6M ﹤0.01% 2222
2021
Q3
$24.4M Buy
435,686
+29,181
+7% +$1.63M 0.01% 1597
2021
Q2
$24.7M Buy
406,505
+33,967
+9% +$2.06M 0.01% 1577
2021
Q1
$26.1M Sell
372,538
-37,641
-9% -$2.64M 0.01% 1491
2020
Q4
$24.5M Buy
410,179
+120,641
+42% +$7.22M 0.01% 1418
2020
Q3
$17.4M Buy
289,538
+46,733
+19% +$2.81M ﹤0.01% 1568
2020
Q2
$12.7M Sell
242,805
-104,822
-30% -$5.5M ﹤0.01% 1799
2020
Q1
$11.7M Buy
347,627
+19,401
+6% +$651K ﹤0.01% 1712
2019
Q4
$14.9M Buy
328,226
+27,913
+9% +$1.26M ﹤0.01% 1804
2019
Q3
$11.4M Buy
300,313
+13,391
+5% +$510K ﹤0.01% 1857
2019
Q2
$12.5M Sell
286,922
-297,035
-51% -$12.9M ﹤0.01% 1849
2019
Q1
$22.2M Sell
583,957
-50,813
-8% -$1.93M 0.01% 1548
2018
Q4
$27.3M Buy
634,770
+118,615
+23% +$5.1M 0.01% 1337
2018
Q3
$25.4M Buy
516,155
+358,500
+227% +$17.6M 0.01% 1506
2018
Q2
$5.05M Sell
157,655
-83,606
-35% -$2.68M ﹤0.01% 2398
2018
Q1
$7.52M Buy
241,261
+97,328
+68% +$3.03M ﹤0.01% 2103
2017
Q4
$6.57M Sell
143,933
-259,841
-64% -$11.9M ﹤0.01% 2133
2017
Q3
$15.2M Sell
403,774
-73,917
-15% -$2.78M ﹤0.01% 1743
2017
Q2
$22.8M Buy
477,691
+72,499
+18% +$3.46M 0.01% 1477
2017
Q1
$18.5M Buy
405,192
+297,355
+276% +$13.6M 0.01% 1548
2016
Q4
$3.48M Sell
107,837
-503,207
-82% -$16.3M ﹤0.01% 2396
2016
Q3
$20.9M Buy
611,044
+51,996
+9% +$1.78M 0.01% 1446
2016
Q2
$18.9M Sell
559,048
-167,400
-23% -$5.65M 0.01% 1417
2016
Q1
$38.5M Buy
726,448
+124,192
+21% +$6.58M 0.01% 1040
2015
Q4
$46.2M Sell
602,256
-489,587
-45% -$37.6M 0.01% 933
2015
Q3
$44.9M Buy
1,091,843
+258,240
+31% +$10.6M 0.02% 873
2015
Q2
$59M Buy
833,603
+747,299
+866% +$52.8M 0.02% 774
2015
Q1
$7.67M Buy
86,304
+56,412
+189% +$5.01M ﹤0.01% 1799
2014
Q4
$2.65M Sell
29,892
-40,438
-57% -$3.58M ﹤0.01% 2342
2014
Q3
$6.82M Buy
70,330
+51,222
+268% +$4.96M ﹤0.01% 1805
2014
Q2
$1.76M Buy
19,108
+8,601
+82% +$790K ﹤0.01% 2622
2014
Q1
$735K Buy
10,507
+3,812
+57% +$267K ﹤0.01% 3161
2013
Q4
$385K Sell
6,695
-2,303
-26% -$132K ﹤0.01% 3570
2013
Q3
$433K Buy
8,998
+1,967
+28% +$94.7K ﹤0.01% 3392
2013
Q2
$204K Buy
+7,031
New +$204K ﹤0.01% 3627